BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20942100)

  • 1. [HCV associated antibodies (anti-HCV, anti-HCV core, anti-C14, anti-NS)].
    Ishikawa K; Koyama T; Isobe N
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():446-9. PubMed ID: 20942100
    [No Abstract]   [Full Text] [Related]  

  • 2. Simultaneous detection of anti-HCV antibody and HCV core antigen.
    Ansaldi F; Icardi G
    Methods Mol Biol; 2009; 510():15-23. PubMed ID: 19009250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the full-length HCV core subgenome from HCV gentoype-1a and genotype-3a and evaluation of the antigenicity of translational products.
    Ansari MA; Irshad M; Agarwal SK; Chosdol K
    Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):806-13. PubMed ID: 23442416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype dependence of peptide-based immunoassays for the detection of HCV core antibodies.
    Muerhoff AS; Gutierrez R; Kyrk C; Leary T; Schlauder G; Dawson G; Desai SM
    J Med Virol; 2008 Mar; 80(3):411-8. PubMed ID: 18205228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of antibodies to hepatitis C virus: false-negative results in an automated chemiluminescent microparticle immunoassay (ARCHITECT Anti-HCV) compared to a microparticle enzyme immunoassay (AxSYM HCV Version 3.0).
    Myrmel H; Navaratnam V; Asjø B
    J Clin Virol; 2005 Nov; 34(3):211-5; discussion 216-8. PubMed ID: 16112611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Spontaneous HCV clearance: an association with gender, age, viral genotypes, infection transmission routes, and markers of HBV and HIV].
    Fedorchenko SV; Martynovich TL; Liashok OV; Kariuk ZhA; Ianchenko VI
    Ter Arkh; 2010; 82(3):52-6. PubMed ID: 20564924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of core and NS4B synthetic peptide-based immunoassays for the detection of hepatitis C virus antibodies in clinical samples from Cameroon, Central Africa.
    Njouom R; Nerrienet E; Budkowska A; Maillard P; Rousset D; Kalinina O; Mavromara P;
    J Clin Virol; 2010 Sep; 49(1):61-4. PubMed ID: 20621554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic tests: Hepatitis C virus-related antibody].
    Tanaka T
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():411-4. PubMed ID: 16111288
    [No Abstract]   [Full Text] [Related]  

  • 9. IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation.
    Negro F; Giostra E; Rubbia-Brandt L; Mentha G; Colucci G; Morel P; Quadri R; Perrin L; Hadengue A
    J Med Virol; 1998 Nov; 56(3):224-9. PubMed ID: 9783689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the performance of the EIAgen HCV test for detection of hepatitis C virus infection.
    Rao HY; Ren FR; Guan WL; Houde M; Du SC; Liu CL; Gong XY; Wei L
    J Virol Methods; 2009 Dec; 162(1-2):203-7. PubMed ID: 19703491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of prevalence of anti-hepatitis C virus antibodies in differing South American populations.
    Robinson JW; Rosas M; Guzman F; Patarroyo ME; Moreno A
    J Med Virol; 1996 Oct; 50(2):188-92. PubMed ID: 8915886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals.
    Valcavi P; Medici MC; Casula F; Arcangeletti MC; De Conto F; Pinardi F; Calderaro A; Chezzi C; Dettori G
    J Med Virol; 2004 Jul; 73(3):397-403. PubMed ID: 15170635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical importance of assessment of anti-HCV IgM antibodies in chronic hepatitis C.
    Stránský J; Honzáková E; Vandasová J; Horejsová M; Kyncl J; Nĕmecek V; Horák J
    Acta Virol; 1996 Apr; 40(2):61-5. PubMed ID: 8886113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Quantitative assay of anti-HCV core antibody with JCC-2 ELISA: anti-HCV core IgG antibody].
    Nakashima T; Mizuno K
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):247-52. PubMed ID: 7563711
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical significance and problems in HCV measurement--comparison of CLEIA method with PCR method].
    Ohta H; Takemura M; Furuta N; Akiyama M; Katagiri Y; Ohashi H; Takahashi K; Saito K; Seishima M
    Rinsho Byori; 2004 Oct; 52(10):813-8. PubMed ID: 15624496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic utility of hepatitis C virus core antigen in hemodialysis patients.
    Medhi S; Potukuchi SK; Polipalli SK; Swargiary SS; Deka P; Chaudhary A; Begum N; Hussain Z; Ahlawat RS; Kar P
    Clin Biochem; 2008 May; 41(7-8):447-52. PubMed ID: 18267117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A highly sensitive and specific enzyme-linked immunosorbent assay of antibodies to hepatitis C virus.
    Eroglu C; Yildiz E; Ozturk M; Pinarbasi E
    Acta Virol; 2000 Feb; 44(1):29-33. PubMed ID: 10989689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory diagnostics for hepatitis C virus infection.
    Kamili S; Drobeniuc J; Araujo AC; Hayden TM
    Clin Infect Dis; 2012 Jul; 55 Suppl 1():S43-8. PubMed ID: 22715213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-HCV assays: first or second generation?
    Vanpachtenbeke M
    Vox Sang; 1993; 64(2):132. PubMed ID: 7681243
    [No Abstract]   [Full Text] [Related]  

  • 20. Simultaneous detection of hepatitis C virus antigen and antibodies in dried blood spots.
    Brandão CP; Marques BL; Marques VA; Villela-Nogueira CA; Do Ó KM; de Paula MT; Lewis-Ximenez LL; Lampe E; Sá Ferreira JA; Villar LM
    J Clin Virol; 2013 Jun; 57(2):98-102. PubMed ID: 23518440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.